LONDON, Nov 7 (Reuters) – Europe’s medicines regulator has
written to AstraZeneca asking it to provide more
information about a U.S. probe into a clinical trial of the
company’s new heart drug Brilinta.
AstraZeneca is relying on Brilinta as a key driver of
near-term sales and profit growth, and the unusual decision by
the U.S. Department of Justice (DOJ) to launch an investigation
has raised concerns about the product’s future.
LONDON (Reuters) – The hunt is on for 100,000 British volunteers to post their genetic information online in the name of science as a North American open-access DNA project arrives in Europe.
The launch of the Personal Genome Project UK on Thursday offers the public a chance to learn more about their own genetic profiles and contribute to advances in medical science – but it also poses ethical challenges.
LONDON, Nov 6 (Reuters) – Britain’s Department of Health
unveiled a new five-year scheme on Wednesday to curb
prescription drug prices and ensure the state healthcare system
gets good value for money.
The cost of branded medicines to the National Health Service
will be held flat for two years under the latest version of the
pharmaceutical price regulation scheme, or PPRS.
COPENHAGEN (Reuters) – Drug pricing is emerging as a key challenge for Novo Nordisk, the world’s biggest insulin producer, whose previously unstoppable growth has started to flag, according to the Danish firm’s chief executive.
Lars Sorensen is certain of one thing: the number of potential customers for his products is going to keep on rising as a global obesity epidemic tips more people into type 2 diabetes in the West and many developing nations.
LONDON (Reuters) – AstraZeneca is being investigated by U.S. authorities over a major clinical trial that was used to win marketing approval for its new heart drug Brilinta, casting fresh doubts over the medicine.
Brilinta sales have been a disappointment since its launch two years ago, although AstraZeneca has recently stepped up marketing efforts and hopes that further clinical tests will underscore its value in preventing heart attacks.